Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.99 | N/A |
| PEG Ratio (TTM) | -16.36 | N/A |
| P/S Ratio (TTM) | 1.82 | N/A |
| P/B Ratio (TTM) | 1.04 | N/A |
| P/FCF Ratio (TTM) | 9.24 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.72 | N/A |
| Price to 5YR AVG FCF Ratio | 18.58 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.72% | N/A |
| ROE (TTM) | 8.35% | N/A |
| Net Profit Margin (TTM) | 14.06% | N/A |
| ROIC 5YR AVG | 9.90% | N/A |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -0.68% | 8.01% | 0.29% |
| Revenue | 3.12% | 26.69% | 26.38% |
| Net Income | -0.70% | 19.77% | 15.07% |
| Cash Flow | 18.34% | -123.34% | -75.94% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.89 | N/A |
| Quick Ratio (TTM) | 0.89 | N/A |
| D/E Ratio (TTM) | 0.90 | N/A |
| Interest Coverage (TTM) | 1.01 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.22 | N/A |
| LTL to 5YR AVG FCF | 11.05 | N/A |
| Shares Outstanding Growth 5YR AVG | 17.14% | N/A |